CLEAN ENERGY FUELS CORP (CLNE)

US1844991018 - Common Stock

2.65  -0.21 (-7.34%)

After market: 2.77 +0.12 (+4.53%)

Fundamental Rating

3

Overall CLNE gets a fundamental rating of 3 out of 10. We evaluated CLNE against 204 industry peers in the Oil, Gas & Consumable Fuels industry. While CLNE seems to be doing ok healthwise, there are quite some concerns on its profitability. CLNE is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

CLNE had positive earnings in the past year.
CLNE had a positive operating cash flow in the past year.
In the past 5 years CLNE reported 4 times negative net income.
In the past 5 years CLNE always reported a positive cash flow from operatings.

1.2 Ratios

CLNE has a worse Return On Assets (-5.75%) than 89.16% of its industry peers.
Looking at the Return On Equity, with a value of -9.88%, CLNE is doing worse than 83.25% of the companies in the same industry.
Industry RankSector Rank
ROA -5.75%
ROE -9.88%
ROIC N/A
ROA(3y)-7.68%
ROA(5y)-4.36%
ROE(3y)-11.43%
ROE(5y)-6.48%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CLNE has a Gross Margin of 29.73%. This is in the lower half of the industry: CLNE underperforms 60.59% of its industry peers.
In the last couple of years the Gross Margin of CLNE has declined.
CLNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.26%
GM growth 5Y-13.03%

4

2. Health

2.1 Basic Checks

CLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLNE has more shares outstanding than it did 1 year ago.
CLNE has more shares outstanding than it did 5 years ago.
CLNE has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.17, we must say that CLNE is in the distress zone and has some risk of bankruptcy.
CLNE has a Altman-Z score of 0.17. This is in the lower half of the industry: CLNE underperforms 70.44% of its industry peers.
A Debt/Equity ratio of 0.37 indicates that CLNE is not too dependend on debt financing.
CLNE's Debt to Equity ratio of 0.37 is in line compared to the rest of the industry. CLNE outperforms 52.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z 0.17
ROIC/WACCN/A
WACC8.47%

2.3 Liquidity

CLNE has a Current Ratio of 3.06. This indicates that CLNE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.06, CLNE belongs to the top of the industry, outperforming 80.30% of the companies in the same industry.
A Quick Ratio of 2.74 indicates that CLNE has no problem at all paying its short term obligations.
The Quick ratio of CLNE (2.74) is better than 79.80% of its industry peers.
Industry RankSector Rank
Current Ratio 3.06
Quick Ratio 2.74

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 150.00% over the past year.
CLNE shows a decrease in Revenue. In the last year, the revenue decreased by -4.33%.
CLNE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.18% yearly.
EPS 1Y (TTM)150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.21%
Revenue 1Y (TTM)-4.33%
Revenue growth 3Y13.38%
Revenue growth 5Y4.18%
Sales Q2Q%9.74%

3.2 Future

CLNE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 61.07% yearly.
The Revenue is expected to grow by 13.93% on average over the next years. This is quite good.
EPS Next Y60.34%
EPS Next 2Y-24.84%
EPS Next 3Y38.02%
EPS Next 5Y61.07%
Revenue Next Year-2.84%
Revenue Next 2Y-0.43%
Revenue Next 3Y4.39%
Revenue Next 5Y13.93%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 88.33 indicates a quite expensive valuation of CLNE.
CLNE's Price/Earnings ratio is a bit more expensive when compared to the industry. CLNE is more expensive than 75.37% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.53, CLNE is valued quite expensively.
The Forward Price/Earnings Ratio is negative for CLNE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 88.33
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLNE is valued a bit more expensive than 79.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 36.82

4.3 Compensation for Growth

CLNE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CLNE's earnings are expected to grow with 38.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.46
PEG (5Y)N/A
EPS Next 2Y-24.84%
EPS Next 3Y38.02%

0

5. Dividend

5.1 Amount

CLNE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEAN ENERGY FUELS CORP

NASDAQ:CLNE (11/15/2024, 8:00:21 PM)

After market: 2.77 +0.12 (+4.53%)

2.65

-0.21 (-7.34%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap592.17M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 88.33
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.46
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.75%
ROE -9.88%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 29.73%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.06
Quick Ratio 2.74
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)150%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y60.34%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-4.33%
Revenue growth 3Y13.38%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y